DK0710689T3 - Polymere antitumormidler - Google Patents

Polymere antitumormidler

Info

Publication number
DK0710689T3
DK0710689T3 DK95307637T DK95307637T DK0710689T3 DK 0710689 T3 DK0710689 T3 DK 0710689T3 DK 95307637 T DK95307637 T DK 95307637T DK 95307637 T DK95307637 T DK 95307637T DK 0710689 T3 DK0710689 T3 DK 0710689T3
Authority
DK
Denmark
Prior art keywords
tumor agents
polymeric anti
agents
polymeric
mammal
Prior art date
Application number
DK95307637T
Other languages
English (en)
Inventor
Hwei-Ru Tsou
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0710689T3 publication Critical patent/DK0710689T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/028—Polyamidoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0273—Polyamines containing heterocyclic moieties in the main chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DK95307637T 1994-11-01 1995-10-26 Polymere antitumormidler DK0710689T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33266194A 1994-11-01 1994-11-01
US08/521,505 US5609867A (en) 1994-11-01 1995-08-29 Polymeric antitumor agents

Publications (1)

Publication Number Publication Date
DK0710689T3 true DK0710689T3 (da) 2003-08-04

Family

ID=26988319

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95307637T DK0710689T3 (da) 1994-11-01 1995-10-26 Polymere antitumormidler

Country Status (11)

Country Link
US (1) US5609867A (da)
EP (1) EP0710689B1 (da)
JP (1) JPH08253420A (da)
AT (1) ATE239047T1 (da)
AU (1) AU690740B2 (da)
CA (1) CA2161603A1 (da)
DE (1) DE69530552T2 (da)
DK (1) DK0710689T3 (da)
ES (1) ES2197183T3 (da)
PT (1) PT710689E (da)
TW (1) TW383318B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0874643B1 (en) * 1996-02-15 2001-11-21 J. Paul Santerre Bioresponsive pharmacologically-active polymers and articles made therefrom
KR20160099081A (ko) 2013-07-26 2016-08-19 업데이트 파마 인코포레이트 비산트렌의 치료 효과 개선용 조합 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714993A (en) 1970-11-23 1973-02-06 Hughes Tool Co Valving tube subassembly for percussion bit
US4197249A (en) 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
US4526788A (en) * 1983-03-18 1985-07-02 American Cyanamid Company Polymeric[[(oxazolidinyl)alkyl]amino]anthraquinones
US4520162A (en) * 1983-09-24 1985-05-28 Director-General Of The Agency Of Industrial Science & Technology Polymeric compounds with sustained anti-tumor activity and a method for the preparation thereof
GB8413464D0 (en) 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
DE3768419D1 (de) * 1986-10-07 1991-04-11 Boehringer Biochemia Srl Pharmazeutische zusammensetzungen mit antineoplastischer wirkung.
US5378456A (en) * 1993-03-25 1995-01-03 American Cyanamid Company Antitumor mitoxantrone polymeric compositions

Also Published As

Publication number Publication date
AU690740B2 (en) 1998-04-30
TW383318B (en) 2000-03-01
EP0710689A2 (en) 1996-05-08
ES2197183T3 (es) 2004-01-01
CA2161603A1 (en) 1996-05-02
PT710689E (pt) 2003-08-29
EP0710689A3 (en) 1996-11-20
US5609867A (en) 1997-03-11
JPH08253420A (ja) 1996-10-01
DE69530552T2 (de) 2003-11-20
ATE239047T1 (de) 2003-05-15
AU3454795A (en) 1996-05-09
EP0710689B1 (en) 2003-05-02
DE69530552D1 (de) 2003-06-05

Similar Documents

Publication Publication Date Title
PT639577E (pt) Eteres fosfono-oximetilicos ou metiltiometilicos de derivados do taxano como agentes anti-tumor
DE3865817D1 (da)
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
NZ225339A (en) Compounds having biocidal properties and pharmaceutical compositions
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
ES8704931A1 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
IN170909B (da)
EP0351865A3 (en) Dc-89 compounds and process for their preparation
DE69711996T2 (de) 2-Aminobenzazepin-Derivate und ihre Verwendung für die Behandlung von Immunosuppression
DE69124844D1 (de) Radicicol-Derivate, ihre Herstellung und ihre Antitumorwirkung
DE69530552T2 (de) Polymere Antitumormittel
ES2020953B3 (es) Complejos de tetrahidro-3,4-furanodiamina-n-n'platino.
EP1073447A4 (en) N1-MODIFIED GLYCOPEPTIDES
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
EP0297594A3 (en) Novel 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives
NO905468L (no) Pesticidblandinger.
WO2000000469A3 (en) Alkyl ketones as potent anti-cancer agents
DE3767728D1 (en) Hydroxylierte 1,2-diamincyclohexan platinkomplexe.
TW221051B (da)
EP1607399A3 (en) BIS-(N,N'-BIS-(2-Haloethyl)Amino) Phosphoramidates as antitumor agents
EP1011329A4 (en) PACLITAXELS 7-METHYLTHIOOXOMETHYLE AND 7-METHYLTHIODIOXOMETHYLE
IL161920A0 (en) Photochromic oxazine compounds and methods for their manufacture
HU0200034D0 (en) Process for the preparation of midodrine
DE60003560D1 (de) 1,2-dihydro-1-oxo-pyrazino[1,2-]indolederivate